Related references
Note: Only part of the references are listed.Non-invasive Assessment of Skin Microvascular Function in Humans: An Insight Into Methods
Matthieu Roustit et al.
MICROCIRCULATION (2012)
Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study
Fariborz Mobarrez et al.
THROMBOSIS RESEARCH (2012)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans
Lacy A. Holowatz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Functional Dilator Capacity is Independently Associated with Insulin Sensitivity and Age in Central Obesity and is not Improved by High Dose Statin Treatment
Geraldine F. Clough et al.
MICROCIRCULATION (2011)
Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
Michael S. Kostapanos et al.
Current Vascular Pharmacology (2010)
Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
William L. Baker et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia
Sara Tehrani et al.
THROMBOSIS RESEARCH (2010)
Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
Helen M. Colhoun et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk
Thomas Forst et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
The human cutaneous circulation as a model of generalized microvascular function
Lacy A. Holowatz et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
The prevention of diabetic microvascular complications of diabetes: Is there a role for lipid lowering?
LA Leiter
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Early microvascular dysfunction in healthy normal-weight males with heredity for type 2 diabetes
G Jörneskog et al.
DIABETES CARE (2005)
Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy
FR Danesh et al.
FASEB JOURNAL (2004)
Type 1 and type 2 diabetic patients display different patterns of cellular microparticles
F Sabatier et al.
DIABETES (2002)
Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia
K Sen et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2002)
Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients
J Skrha et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2001)
Lipid modulation in insulin-dependent diabetes mellitus - Effect on microvascular outcomes
LF Fried et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2001)
Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes
F Khan et al.
DIABETES CARE (2000)